SenzaGen AB (SenzaGen) has raised approximately 100 MSEK through a private placement and a preferential rights issue of shares.

SenzaGen provides in vitro testing for the cosmetic, chemical and pharmaceutical industries, which obviates the need for animal testing. The company is listed on Nasdaq First North Growth Market in Stockholm.

Vator Securities acted as financial advisor and Baker McKenzie acted as legal advisor to SenzaGen in connection with the transactions. Baker McKenzie's team consisted of Joakim Falkner, Stefan Balazs, Ian Gulam and Per Blom.

Explore Our Newsroom
See All News